Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease

被引：0

作者：

Volkmann, Elizabeth R. ^{[1
]}

Roth, Michael ^{[1
]}

Elashoff, Robert ^{[2
]}

Clements, Philip J. ^{[1
]}

Furst, Daniel E. ^{[1
]}

Khanna, Dinesh ^{[3
]}

Goldin, Jonathan ^{[4
]}

Tashkin, Donald ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Biomath, Los Angeles, CA 90095 USA

[3] Univ Michigan, Med, Ann Arbor, MI 48109 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1076

引用

页数：2

共 50 条

[31] \ Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis-Related Interstitial Lung Disease [J].

Tiwari, Vivekanand ;

Rigby, William F. C. .

ACR OPEN RHEUMATOLOGY, 2022, 4 (02) :119-122

[32] The Ambitious Goal of Validating Prognostic Biomarkers for Systemic Sclerosis-related Interstitial Lung Disease [J].

Bonella, Francesco ;

Caramaschi, Paola .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) :1034-1036

[33] Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies [J].

Volkmann, Elizabeth R. ;

Tashkin, Donald P. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) :2045-2056

[34] Predicting Mortality in Systemic Sclerosis-Related Interstitial Lung Disease in Two Independent Cohorts [J].

Tashkin, D. P. ;

Volkmann, E. ;

Sim, M. ;

Roth, M. ;

Clements, P. ;

Furst, D. E. ;

Elashoff, R. ;

Keyes-Elstein, L. ;

Pinckney, A. ;

Goldlmuntz, E. ;

Sullivan, K. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

[35] TREATMENT WITH CYCLOPHOSPHAMIDE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE DOES NOT IMPROVE SURVIVAL AFTER 12 YEARS OF FOLLOW UP [J].

Volkmann, E. R. ;

Sim, M. ;

Tashkin, D. P. ;

Khanna, D. ;

Clements, P. J. ;

Roth, M. ;

Furst, D. ;

Pickney, A. ;

Goldmuntz, E. ;

Keyes-Elstein, L. ;

Elashoff, R. ;

Sullivan, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :104-104

[36] A RETROSPECTIVE DESCRIPTIVE ANALYSIS OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AND PULMONARY HYPERTENSION [J].

Rowe, Anthony ;

Ratwani, Ankush ;

Barnett, Scott ;

King, Christopher ;

Shlobin, Oksana ;

Nathan, Steven .

CHEST, 2020, 158 (04) :1878A-1879A

[37] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study [J].

Panopoulos, Stylianos T. ;

Bournia, Vassiliki-Kalliopi ;

Trakada, Georgia ;

Giavri, Irene ;

Kostopoulos, Charalambos ;

Sfikakis, Petros P. .

LUNG, 2013, 191 (05) :483-489

[38] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study [J].

Stylianos T. Panopoulos ;

Vassiliki-Kalliopi Bournia ;

Georgia Trakada ;

Irene Giavri ;

Charalambos Kostopoulos ;

Petros P. Sfikakis .

Lung, 2013, 191 :483-489

[39] Occupational Exposures and Systemic Sclerosis-Related Lung Disease [J].

Volkmann, Elizabeth R. .

CHEST, 2022, 161 (04) :874-875

[40] PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER THE LUNG TRANSPLANTATION: A RETROSPECTIVE STUDY [J].

Nakayama, Y. ;

Nakashima, R. ;

Handa, T. ;

Ohsumi, A. ;

Yamada, Y. ;

Nakajima, D. ;

Yutaka, Y. ;

Tanaka, S. ;

Hamada, S. ;

Ikezoe, K. ;

Tanizawa, K. ;

Shirakashi, M. ;

Hiwa, R. ;

Tsuji, H. ;

Kitagori, K. ;

Akizuki, S. ;

Yoshifuji, H. ;

Date, H. ;

Morinobu, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :160-161

← 1 2 3 4 5 →